Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: A retrospective study from the Rare Cancer Network

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 1, 2006, Pages 179-186

  Weber, Damien C ^a,m   Miller, Robert C ^b   Villà, Salvador ^c   Hanssens, Patrick ^d   Baumert, Brigitta G ^e   Castadot, Pierre ^f   Varlet, Pascale ^g   Abacioglu, Ufuk ^h   Igdem, Sefik ⁱ   Szutowicz, Ewa ^j   Nishioka, Hiroshi ^k   Hofer, Silvia ^l   Rutz, Hans Peter ^m   Ozsahin, Mahmut ⁿ   Taghian, Alphonse ^o   Mirimanoff, René O ⁿ  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b MAYO CLINIC   (United States)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^e MAASTRO CLINIC   (Netherlands)

^f JULES BORDET INSTITUTE   (Belgium)

^g CENTRE HOSPITALIER SAINTE ANNE   (France)

^h MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

ⁱ Metropolitan Hospital   (Turkey)

^j MEDICAL UNIVERSITY OF GDANSK   (Poland)

^k TOKYO MEDICAL UNIVERSITY   (Japan)

^l UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^m PAUL SCHERRER INSTITUTE   (Switzerland)

ⁿ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^o MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Cerebellar glioblastoma; Chemotherapy; Malignant glioma; Posterior fossa tumors; Radiotherapy

Indexed keywords

APPROXIMATION THEORY; CHEMOTHERAPY; NEUROSURGERY; PATIENT MONITORING; SALVAGING; TUMORS;

CEREBELLAR GLIOBLASTOMA; MALIGNANT GLIOMA; POSTERIOR FOSSA TUMORS;

RADIOTHERAPY;

CARMUSTINE; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; BRAIN STEM; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CEREBELLUM GLIOBLASTOMA MULTIFORME; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MALE; MULTIVARIATE ANALYSIS; NEUROSURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT FAILURE; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBELLAR NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RARE DISEASES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33746804990     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.04.035     Document Type: Article

References (40)

1. Occhiogrosso M., Spada A., Merlicco G., et al. Malignant cerebellar astrocytoma. Report of five cases. J Neurosurg Sci 29 (1985) 43-50
2. Masucci E.F., Ferrero A.A., Kurtzke J.F., et al. Glioblastoma multiforme involving the posterior fossa. Case report and review of literature. Dis Nerv Syst 27 (1966) 47-51
3. Levine S., McKeever P., and Greenberg H. Primary cerebellar glioblastoma multiforme. J Neurooncol 5 (1987) 231-236
4. Georges P.M., Noterman J., and Flament-Durand J. Glioblastoma of the cerebellum in children and adolescents. Case report and review of the literature. J Neurooncol 1 (1983) 275-278
5. Demir M.K., Hakan T., Akinci O., et al. Primary cerebellar glioblastoma multiforme. Diagn Interv Radiol 11 (2005) 83-86
6. Pato-Pato A., Cimas-Hernando I., Lorenzo-Gonzalez J.R., et al. Cerebellar glioblastoma multiforme. a case report. Rev Neurol 38 (2004) 839-842
7. Salazar O.M. Primary malignant cerebellar astrocytomas in children. a signal for postoperative craniospinal irradiation. Int J Radiat Oncol Biol Phys 7 (1981) 1661-1665
8. Carmichael E. Cerebral gliomata. J Path Bact 31 (1928) 493-510
9. Nishioka H., Saito F., Haraoka J., et al. Glioblastoma of the cerebellum. report of an autopsy case associated with intratumoral hemorrhage and CSF seedings. No Shinkei Geka 19 (1991) 547-552
10. Kopelson G., and Linggood R. Infratentorial glioblastoma. the role of neuraxis irradiation. Int J Radiat Oncol Biol Phys 8 (1982) 999-1003
11. Salazar O.M., Rubin P., McDonald J.V., et al. Patterns of failure in intracranial astrocytomas after irradiation. analysis of dose and field factors. AJR Am J Roentgenol 126 (1976) 279-292
12. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
13. Kaplan E., and Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 53 (1958) 457-481
14. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35 (1977) 1-39
15. Cox D.R. Regression models and life tables. J R Stat Soc 34 (1972) 187-220
16. Parsa A.T., Wachhorst S., Lamborn K.R., et al. Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults. J Neurosurg 102 (2005) 622-628
17. Athanassiou H., Synodinou M., Maragoudakis E., et al. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol 23 (2005) 2372-2377
18. DeAngelis L.M. Brain tumors. N Engl J Med 344 (2001) 114-123
19. Kopelson G. Cerebellar glioblastoma. Cancer 50 (1982) 308-311
20. Caldwell W.L., and Aristizabal S.A. Treatment of glioblastoma multiforme. A review. Acta Radiol Ther Phys Biol 14 (1975) 505-512
21. Ramsey R.G., and Brand W.N. Radiotherapy of glioblastoma multiforme. J Neurosurg 39 (1973) 197-202
22. Lee F. Radiation of infratentorial and supratentorial brain-stem tumors. J Neurosurg 43 (1975) 65-68
23. Walker M.D., Strike T.A., and Sheline G.E. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5 (1979) 1725-1731
24. Miller P.J., Hassanein R.S., Giri P.G., et al. Univariate and multivariate statistical analysis of high-grade gliomas. the relationship of radiation dose and other prognostic factors. Int J Radiat Oncol Biol Phys 19 (1990) 275-280
25. Plowman J., Waud W.R., Koutsoukos A.D., et al. Preclinical antitumor activity of temozolomide in mice. efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 54 (1994) 3793-3799
26. Newlands E.S., O'Reilly S.M., Glaser M.G., et al. The Charing Cross Hospital experience with temozolomide in patients with gliomas. Eur J Cancer 32A (1996) 2236-2241
27. Yung W.K., Prados M.D., Yaya-Tur R., et al., Temodal Brain Tumor Group. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol 17 (1999) 2762-2771
28. Ostermann S., Csajka C., Buclin T., et al. Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin Cancer Res 10 (2004) 3728-3736
29. Meikle S.R., Matthews J.C., Brock C.S., et al. Pharmacokinetic assessment of novel anti-cancer drugs using spectral analysis and positron emission tomography. a feasibility study. Cancer Chemother Pharmacol 42 (1998) 183-193
30. Silbergeld D.L., Rostomily R.C., and Alvord Jr. E.C. The cause of death in patients with glioblastoma is multifactorial. clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults. J Neurooncol 10 (1991) 179-185
31. Buckner J. Factors inflencing survival in high-grade glioma. Semin Oncol 30 (2003) 10-14
32. Chang C.H., Housepian E.M., and Herbert Jr. C. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 93 (1969) 1351-1359
33. Bailey C.C., Gnekow A., Wellek S., et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 25 (1995) 166-178
34. Freeman C.R., and Farmer J.P. Pediatric brain stem gliomas. a review. Int J Radiat Oncol Biol Phys 40 (1998) 265-271
35. Guillamo J.S., Monjour A., Taillandier L., et al. Brainstem gliomas in adults. prognostic factors and classification. Brain 124 (2001) 2528-2539
36. Jallo G.I., Biser-Rohrbaugh A., and Freed D. Brainstem gliomas. Childs Nerv Syst 20 (2004) 143-153
37. Selvapandian S., Rajshekhar V., and Chandy M.J. Brainstem glioma. comparative study of clinico-radiological presentation, pathology and outcome in children and adults. Acta Neurochir (Wien) 141 (1999) 721-726 discussion 726-727
38. Landolfi J.C., Thaler H.T., and DeAngelis L.M. Adult brainstem gliomas. Neurology 51 (1998) 1136-1139
39. Linstadt D.E., Edwards M.S., Prados M., et al. Hyperfractionated irradiation for adults with brainstem gliomas. Int J Radiat Oncol Biol Phys 20 (1991) 757-760
40. Curran Jr. W.J., Scott C.B., Horton J., et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85 (1993) 704-710